Akoya Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 77.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
35.7%	Telegraph Hill Partners	17,675,247	US$49.1m	0%	20.77%
9.49%	Blue Water Life Science Advisors, LP	4,697,785	US$13.1m	0%	10.37%
7.11%	PS Capital Partners, LLC	3,517,360	US$9.8m	0%	no data
6.22%	aMoon Fund	3,077,195	US$8.6m	0%	13.96%
3.03%	BlackRock, Inc.	1,501,887	US$4.2m	11.4%	no data
2.96%	The Vanguard Group, Inc.	1,463,853	US$4.1m	0.66%	no data
1.99%	Matthew Winkler	984,513	US$2.7m	0%	no data
1.25%	Garry Nolan	616,913	US$1.7m	0%	no data
1.14%	Geode Capital Management, LLC	562,123	US$1.6m	9.35%	no data
1.04%	SVB Wealth LLC	515,317	US$1.4m	0%	0.03%
0.88%	State Street Global Advisors, Inc.	434,935	US$1.2m	1.54%	no data
0.76%	Parkman Healthcare Partners LLC	375,536	US$1.0m	-59.1%	0.13%
0.75%	Robert Shepler	369,592	US$1.0m	0%	no data
0.71%	Paragon Associates, Ltd.	350,000	US$973.0k	0%	2.09%
0.67%	Polar Capital Holdings Plc	329,756	US$916.7k	-79.1%	no data
0.59%	Schonfeld Strategic Advisors LLC	294,342	US$818.3k	-21.6%	0.01%
0.47%	Peddock Capital Advisors, LLC	234,926	US$653.1k	-2.13%	0.16%
0.47%	Thomas Raffin	234,592	US$652.2k	0%	no data
0.42%	Northern Trust Global Investments	209,717	US$583.0k	1.12%	no data
0.36%	Bridgeway Capital Management, LLC	179,600	US$499.3k	776%	0.01%
0.36%	Charles Schwab Investment Management, Inc.	175,888	US$489.0k	2.39%	no data
0.33%	GSA Capital Partners LLP	165,766	US$460.8k	951%	0.03%
0.29%	Caspar Towarzystwo Funduszy Inwestycyjnych S.A.	146,000	US$405.9k	24.8%	1.98%
0.29%	Niro Ramachandran	144,799	US$402.5k	0%	no data
0.25%	Osterweis Capital Management, Inc.	126,131	US$350.6k	0%	0.02%